Comparison of the efficacy of Piracetam and probiotic-Piracetam in cyanotic breath holding spells in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201028049175N8

Enrollment

Registered

2021-05-30

Start date

2021-06-22

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breath holding spells. Other abnormalities of breathing

Interventions

Intervention 1: Intervention group:In Piracetam group 55 mg/kg of Piracetam tablet will be given to children, daily for 1 month. Intervention 2: Intervention group:In Probiotic-Piracetam group both of

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Children with cyanotic breath holding spells diagnosed by neurologist Children who have informed consent filling by their parents

Exclusion criteria

Exclusion criteria: Children using corticosteroid drugs Children with underlying disease such as cyanotic heart disease Children with iron deficiency anemia

Design outcomes

Primary

Measure	Time frame
Frequency (number) of cyanotic breath holding spells. Timepoint: Daily. Method of measurement: Filling the questionnaire by the mother.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mojtaba Hashemi

Arak University of Medical Sciences

mojtaba53hashemi@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026